Owensboro facility fully focused on Ebola drug

Owensboro facility fully focused on Ebola drug

LOUISVILLE, KY (AP) - A spokesman says a Kentucky company is hiring more people and is working around the clock on an experimental medicine that was recently used on American aid workers who contracted Ebola.

Reynolds American Inc. acquired Kentucky BioProcessing in January. Reynolds spokesman David Howard told The Courier-Journal (http://cjky.it/1ywbzSj ) the company has put its full focus on the compound ZMapp. Kentucky BioProcessing was contracted by San Diego-based drug maker Mapp Biopharmaceutical to produce ZMapp and makes the compound using tobacco plants.

Howard says limited supplies of the compound, which takes about three months to make, are available.

The drug is still awaiting approval. The organization Samaritan's Purse says ZMapp was used on American aid workers Nancy Writebol and Kent Brantly while they were still in Liberia. Both recovered, but doctors say it's unclear what role ZMapp played.


Information from: The Courier-Journal, http://www.courier-journal.com

(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)